I got hold of the Penalty Order from the recent decision against Johnson & Johnson for Risperdal in South Carolina. I was just reading along, and I saw that sentence up there and it took my breath away. I’ll have more to say about this case, but for now, this is enough. There was […]
The judgement in the South Carolina Risperdal case yesterday focuses our attention on the marketing practices of pharmaceutical companies in the last decade when the Atypical Antipsychotics were introduced. Back then there was a lot of excitement about these new drugs. The first generation neuroleptics were both ‘wonder drugs’ because of their effect on psychotic […]
e e cummings Buffalo Bill’s defunct who used to ride a watersmooth-silver stallion and break onetwothreefourfive pigeonsjustlikethat Jesus he was a handsome man and what i want to know is how do you like your blueeyed boy Mister Death Outlook: Washington University, Saint Louis February 2011 In 2013, the American Psychiatric Association (APA) will publish […]
J&J Is Ordered to Pay $327 Million on Risperdal Deceptive-Marketing Claims Bloomberg By Jef Feeley and Steven Church June 3, 2011 A Johnson & Johnson unit must pay more than $327 million in penalties for deceptively marketing the antipsychotic drug Risperdal as safer and better than competing medicines, a South Carolina judge ruled. J&J’s Ortho-McNeil-Janssen […]
The TMAP/Janssen suit in Texas [coming this month: TMAP finally goes on trial…] has been postponed yet again from June 21st to sometime in November. Meanwhile, I’ve been thinking about the state of things back in those early TMAP days. From today’s perspective, the TMAP Schizophrenia Algorithm seems absurd. It isn’t really an algorithm. It’s […]
As I wandered through the early literature on the Atypical Antipsychotics, I was surprised at the lengths the pharmaceutical companies went to to nit-pick about small differences. I’m sort of used to new medications coming on the scene and finding their place by clinical efficacy as time passes. Doctors don’t listen to all the advertising […]
I know that I’m bad to post graphs, charts, table, flow-sheets, etc., but this one is special. It’s the algorithm for treating Schizophrenia from the Texas Medication Algorithm Project in 1999, and it was as outrageous as they’ve said it was: I knew it was ridiculous reading about it, but I hadn’t seen the actual […]